| Dr Marija Mikulskis Cavana, PHARMD, RPH | |
|
11109 Us Highway 15 501, Unit 1804, Aberdeen, NC 28315-2366 | |
| (910) 692-3048 | |
| (910) 692-3321 |
| Full Name | Dr Marija Mikulskis Cavana |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 11109 Us Highway 15 501, Aberdeen, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952733164 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 22495 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marija Mikulskis Cavana, PHARMD, RPH 11109 Us Highway 15 501, Unit 1804, Aberdeen, NC 28315-2366 Ph: (910) 692-3048 | Dr Marija Mikulskis Cavana, PHARMD, RPH 11109 Us Highway 15 501, Unit 1804, Aberdeen, NC 28315-2366 Ph: (910) 692-3048 |
News Archive
Protalix BioTherapeutics, Inc. (NYSE-Amex:PLX), announced today that it has received notice from the U.S. Food and Drug Administration (FDA) that the FDA's Office of Orphan Products Development has granted orphan drug designation to prGCD, the Company's proprietary plant cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease.
AIS introduces Spectral karyotyping (SKY®) equipment, designed and manufactured by ASI, a leading developer of comprehensive solutions for pathology and cytogenetics. Spectral karyotyping (SKY®) is ASI's novel addition to the cytogenetic tool kit. It is based on a unique electro-optical hardware that enables measuring the spectral image of a metaphase, previously stained, such that each chromosome class has a different color (created typically from different combinations of 5 or more basic dyes).
Neuroinflammation is the key driver of the spread of pathologically misfolded proteins in the brain and causes cognitive impairment in patients with Alzheimer's disease, researchers from the University of Pittsburgh School of Medicine reveal in a paper published today in Nature Medicine.
Solvay Pharmaceuticals, Inc. announced that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release Capsules, the most prescribed pancreatic enzyme replacement therapy (PERT) in the United States, significantly improves a key measure of fat absorption in patients with CF who suffer from exocrine pancreatic insufficiency (EPI).
› Verified 4 days ago
Judith Ann Gunnarson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1804 Center Park, Aberdeen, NC 28315 Phone: 910-692-3048 Fax: 910-692-3321 | |
Francesca Marie Agostini, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1706 N Sandhills Blvd, Aberdeen, NC 28315 Phone: 910-944-1502 | |
Shaunetta Campbell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11109 Us 15 501 Hwy Unit 1804, Aberdeen, NC 28315 Phone: 910-692-7029 | |
Mugtaba Abdalla Eltayeb, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1550 N Sandhills Blvd, Aberdeen, NC 28315 Phone: 910-944-0438 | |
Laura Kessell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1804 Center Park, Harris Teeter, Aberdeen, NC 28315 Phone: 910-692-3048 | |
Daniel Wilson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Turner St, Aberdeen, NC 28315 Phone: 910-692-5171 Fax: 910-692-5060 | |
Himani Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1706 N Sandhills Blvd, Aberdeen, NC 28315 Phone: 910-944-1502 |